Poxel - Pharmaceutical Company set-up to find innovative solutions for metabolic diseases management with a primary focus on type 2 diabetes

Industry partnering

Poxel will develop its pipeline assets until clinical proof-of-concept, after which it will be seeking pharmaceutical industry partners to carry out late-stage clinical development and commercialization. Interested potential partners are invited to contact Poxel.

Sitemap | Legal
© Poxel SA